Lifecore Biomedical Announced That It Has Finalized A Series Of Updated Commercial Arrangements With Its Long-Term Commercial Hyaluronic Acid And CDMO Customer, Alcon To Extend And Expand The Existing CDMO Relationship
Benzinga Newsdesk - Jan 5, 2024, 8:06AM